For research use only. Not for therapeutic Use.
JET-209(CAT: I040991) is a potent and selective small-molecule inhibitor designed for cancer and metabolic disease research. It targets key signaling pathways involved in tumor progression, cellular metabolism, and immune regulation. JET-209 exhibits high binding affinity and specificity, making it a valuable tool for studying targeted therapy approaches and drug resistance mechanisms. Suitable for biochemical, cellular, and preclinical studies, this compound aids in mechanism-of-action investigations and therapeutic development. For research use only; not for human or clinical applications.
| Catalog Number | I040991 |
| Synonyms | 5-[8-[5-acetyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]isoquinolin-3-yl]-N-[1-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]piperidin-4-yl]pyridine-2-carboxamide |
| Molecular Formula | C46H47N9O6 |
| Purity | ≥95% |
| IUPAC Name | 5-[8-[5-acetyl-1-(oxan-4-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]isoquinolin-3-yl]-N-[1-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]piperidin-4-yl]pyridine-2-carboxamide |
| InChI | InChI=1S/C46H47N9O6/c1-27(56)53-18-13-40-37(26-53)43(51-55(40)32-14-19-61-20-15-32)35-4-2-3-28-22-39(48-24-36(28)35)29-5-8-38(47-23-29)44(58)49-31-11-16-52(17-12-31)33-6-7-34-30(21-33)25-54(46(34)60)41-9-10-42(57)50-45(41)59/h2-8,21-24,31-32,41H,9-20,25-26H2,1H3,(H,49,58)(H,50,57,59) |
| InChIKey | OGNHAQXAAGMVOV-UHFFFAOYSA-N |
| SMILES | CC(=O)N1CCC2=C(C1)C(=NN2C3CCOCC3)C4=CC=CC5=CC(=NC=C54)C6=CN=C(C=C6)C(=O)NC7CCN(CC7)C8=CC9=C(C=C8)C(=O)N(C9)C1CCC(=O)NC1=O |
